Principal Investigators
Dr. Ryan Zarychanski, M.D. MSc
Ryan Zarychanski is a Critical Care physician, Hematologist, and Clinician Scientist at the University of Manitoba and CancerCare Manitoba, and is an active member of the CCCTG.
Dr. Zarychanski completed combined fellowships in Critical Care Medicine and Hematology, (University of Manitoba) followed by a Masters degree in Epidemiology and a research fellowship (University of Ottawa) under Drs. Dean Fergusson and Paul Hebert. Dr. Zarychanski’s research focuses on the hematologic aspects of critical illness. His major research program evaluates the efficacy and safety of unfractionated heparin in septic shock – a program that has evolved, with close collaboration from the CCCTG, into an international multicentre randomized controlled trial; the HALO International RCT. Other active programs of research include evaluating IVIG in septic shock, studying the role of Tranexamic acid to reduce transfusion in major non-cardiac surgery, and improving processes of care for patients requiring massive transfusion. He also leads research evaluating thrombocytopenia, transfusion, and anemia in critical illness. Dr. Zarychanski actively supervises graduate students and clinical investigators pursuing careers as clinician-scientists.
Steering Committee
Trial Sites
HEALTH SCIENCES CENTRE | WINNIPEG, MB
Principal Investiagor: Dr. Ryan Zarychanski
Research Coordinator:
ST BONIFACE HOSPITAL | WINNIPEG, MB
Principal Investigator:
Research Coordinator:
JURAVINKSI HOSPITAL | HAMILTON, ON
Principal Investigator:
Research Coordinator:
UNITY HEALTH ST. MICHAEL’S HOSPITAL | TORONTO, ON
Principal Investigator:
Research Coordinator:
OTTAWA HOSPITAL | OTTAWA, ON
Principal Investigator:
Research Coordinators:
CENTRE HOSPITALIER DE L’UNIVERSITÉ DE MONTRÉAL (CHUM) | MONTRÉAL, PQ
Principal Investigator:
Research Coordinator:
QUEEN ELIZABETH II HEALTH SCIENCES CENTRE | HALIFAX, NS
Principal Investigator:
Research Coordinator: